- Home
- NAUT vs ANGO Comparison
NAUT vs ANGO Comparison
Compare NAUT & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAUT | ANGO |
|---|---|---|
| Founded | 2016 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.5M | 420.2M |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | NAUT | ANGO |
|---|---|---|
| Price | $2.54 | $11.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $4.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 350.3K | 246.2K |
| Earning Date | 04-28-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.07 | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.51 |
| Revenue Next Year | $992.86 | $4.96 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $0.62 | $8.36 |
| 52 Week High | $4.31 | $13.99 |
Technical Indicators
Market Signals| Indicator | NAUT | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 64.75 |
| Support Level | $2.43 | $11.40 |
| Resistance Level | $2.54 | $12.72 |
| Average True Range (ATR) | 0.20 | 0.40 |
| MACD | -0.02 | 0.10 |
| Stochastic Oscillator | 27.01 | 82.26 |
Price Performance
Historical ComparisonAbout NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.